PLD4 and systemic lupus erythematosus: In any case, our findings imply that human PLD4 polymorphism and deficiency may have diverse phenotypic presentations ranging from hemophagocytic lymphohistiocytosis to lupus, and that all may be treatable by blockade of TLR9.